Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/04/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has informed BSE that its Board of Directors will meet on Thursday, April 10, 2025 at 3:00 PM at its registered office in Ahmedabad. The Board will consider and approve the audited financial results for the half year and full year ended March 31, 2025, along with the auditor's report. Additionally, the Board will consider a proposal to raise funds through the issue of equity shares and/or warrants on a preferential basis. The trading window for insiders has been closed from April 3, 2025 until 48 hours after the meeting concludes.
This is a preliminary intimation, so no immediate impact on stock price. The preferential issue of equity shares/warrants, if approved, could lead to dilution of existing shareholders. The audited FY25 results will give investors a full-year view of the company's financial health.